| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.12B | 58.07B | 52.26B | 57.88B | 47.24B | 47.79B |
| Gross Profit | 6.66B | 7.14B | 6.39B | 6.20B | 4.36B | 5.07B |
| EBITDA | 2.75B | 3.61B | 3.15B | 3.14B | 1.81B | 2.18B |
| Net Income | 1.87B | 2.31B | 1.67B | 1.65B | 788.13M | 1.05B |
Balance Sheet | ||||||
| Total Assets | 44.80B | 45.16B | 37.63B | 39.70B | 32.63B | 30.98B |
| Cash, Cash Equivalents and Short-Term Investments | 4.12B | 5.19B | 4.22B | 4.49B | 3.37B | 2.72B |
| Total Debt | 11.85B | 9.37B | 6.14B | 4.99B | 2.80B | 2.90B |
| Total Liabilities | 24.83B | 24.59B | 20.74B | 23.62B | 18.90B | 18.60B |
| Stockholders Equity | 19.69B | 20.28B | 16.57B | 15.78B | 13.48B | 12.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.72B | 25.07M | -1.12B | 688.88M | 1.36B |
| Operating Cash Flow | 0.00 | -687.33M | 1.74B | -506.50M | 1.67B | 2.07B |
| Investing Cash Flow | 0.00 | -2.46B | -1.65B | -576.64M | -1.01B | -1.08B |
| Financing Cash Flow | 0.00 | 4.02B | -562.00M | 1.89B | -253.68M | -1.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥14.00B | 9.52 | ― | 3.91% | 12.31% | 1.81% | |
77 Outperform | ¥14.06B | 11.13 | ― | 3.97% | 5.33% | -27.53% | |
70 Outperform | ¥12.30B | 10.64 | ― | 2.16% | 24.11% | 1644.12% | |
70 Outperform | ¥16.09B | 16.82 | ― | 1.39% | 2.98% | 11.88% | |
67 Neutral | ¥15.87B | 12.39 | ― | 3.68% | 5.82% | -22.14% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥15.44B | 22.90 | ― | 5.36% | -3.19% | 109.84% |